Sustainability Considerations for Consumables Used in Microbiological and Biomedical Laboratories [0.03%]
微生物和生物医学实验室消耗品的可持续性考量
Autumn Cerda,Robert Emery,Scott Patlovich
Autumn Cerda
Introduction: The 6th edition of the Biosafety in Microbiological and Biomedical Laboratories includes Appendix L on sustainability that describes a series of considerations for biocontainment facilities. But many biosafe...
Room-Based Assessment of Mobile Air Cleaning Devices Using a Bioaerosol Challenge [0.03%]
基于生物气溶胶挑战的室内空气质量移动净化设备净化效率评估研究
Alan Beswick,Jodi Brookes,Iwona Rosa et al.
Alan Beswick et al.
Introduction: The widespread transmission of the SARS-CoV-2 virus has increased scientific and societal interest in air cleaning technologies, and their potential to mitigate the airborne spread of microorganisms. Here we...
Benjamin Fontes,Danielle Scavone,Wesley Bridges et al.
Benjamin Fontes et al.
Introduction: Yale University designed and constructed a temporary field hospital for 100 COVID-19 symptomatic patients. Conservative biocontainment decisions were made in design and operational practices. Objectives of t...
A Means of Codifying Safety Cross-Training Knowledge Expectations for Biosafety Professionals [0.03%]
用于生物安全专业人员的安全交叉培训知识期望的编码方法
Robert J Emery,Scott J Patlovich,Kristin G King et al.
Robert J Emery et al.
Introduction: The health and safety issues encountered by biosafety professionals in the daily conduct of their work is rarely limited solely to potentially infectious pathogens. A basic understanding of the other types o...
Matthew Philpott,Kathy OReilly,Luiz Bermudez et al.
Matthew Philpott et al.
Introduction: The ongoing COVID-19 pandemic has presented numerous challenges to education at all levels, but has been particularly challenging for professional schools and other educational sectors that require intensive...
Pivoting the Biosafety Program in Response to COVID-19: Recommendations of Key Services and Tasks to Consider for the Next Pandemic [0.03%]
对COVID-19的生物安全计划进行调整:为下一次大流行病考虑的关键服务和任务建议
Robert J Emery,Scott J Patlovich,Kristin G King et al.
Robert J Emery et al.
Introduction: With the onset of the COVID-19 pandemic, a rapid adjustment of work tasks was necessary for many biosafety programs (and other safety programs) to address drastic shifts in workload demands amid pandemic-rel...
FDA Guidance on Shedding and Environmental Impact in Clinical Trials Involving Gene Therapy Products [0.03%]
基因疗法产品临床试验中关于病毒脱落和环境影响的FDA指南文件
Daniel Eisenman,Scott Swindle
Daniel Eisenman
Introduction: The US regulatory environment is evolving to accommodate a boom in gene therapy research. The 2019 version of the National Institutes of Health (NIH) Guidelines on Research Involving Recombinant or Synthetic...
Claudia Gentry-Weeks,Dell Rae Ciaravola,Marc Barker et al.
Claudia Gentry-Weeks et al.
Introduction: Universities were challenged during the COVID-19 pandemic to continue providing quality education for their students while navigating the uncertainties of the SARS-CoV-2 virus. ...
Assessing the Established Competency Categories of the Biosafety, Infection Prevention, and Public Health Professions: A Guide for Addressing Needed Professional Development Training for the Current and Next Pandemic [0.03%]
评估生物安全、感染预防和公共卫生专业既定的职业能力类别:为当前和未来大流行病所需的专业发展培训提供指导手册
Robert J Emery,Scott J Patlovich,Kristin G King et al.
Robert J Emery et al.
A recent series of widespread infectious disease outbreaks has highlighted commonalities and differences between three key professions that operate on the front lines of response in support of research and/or direct healthcare providers: bi...
Monitoring Laboratory Occupational Exposures to Burkholderia pseudomallei [0.03%]
布氏Legionella实验室职业暴露的监测
LaTonya A Clay,Kurtis W Straub,Sherry L Adrianos et al.
LaTonya A Clay et al.
Background: Burkholderia pseudomallei is a Tier 1 overlap select agent and subject to the select agent regulations (42 CFR §73 and 9 CFR §121). It is a gram-negative, motile, soil saprophyte, and the etiologic agent of ...